We are pleased to announce that Jennifer Che, Managing Director of Eagle IP, was a featured panelist at the annual Fordham Intellectual Property Law & Policy Conference held recently in New York City.

Widely regarded as one of the most prestigious gatherings in the IP world, the Fordham Conference brings together judges, practitioners, and policymakers from across the globe to discuss the most pressing issues in the field. Jennifer contributed her expertise to the China panel, where she engaged in a deep-dive discussion regarding the rapidly shifting intellectual property landscape in the region.

At Eagle IP, we remain committed to staying at the forefront of international IP policy. Jennifer’s participation in this high-level forum underscores our dedication to providing our clients with the most current and sophisticated counsel for their global IP portfolios.

Our Past Events

Recommended Insights

A Stratification Too Far? How the CNIPA Draws the Line on Patient Subgroups in a Recent Precision Medicine Invalidation Case

27 February 2026
Precision medicine is rapidly transforming the global healthcare landscape, providing more effective therapies and better patient outcomes through targeted solutions. As therapeutics move away from the traditional “one-size-fits-all” model, unique challenges are presented in the patent examination process. The 2024 Top 10 Patent Re-examination and Invalidation case highlighted below provides further insight into how the […]

CHINA DIVISIONAL PATENT STRATEGY: Recent Judgment Narrows What Constitutes “Different Inventions” for Divisionals

6 December 2021
In China, patents applicants take advantage of a commonly-used divisional filing strategy to achieve a fine-tuned balance between protection scope and protection period (if used properly). Patent applicants (especially foreign applicants) widely welcome this well-established strategy, and up until now, have used it with much success. In fact, we recommend this strategy and have even […]

Breaking: China Released New Implementation Measures for the New Patent Linkage System

14 July 2021
On July 4, 2021, China’s National Medical Products Administration (NMPA) and the China National Intellectual Property Administration (CNIPA) released details on the new implementation measures for early dispute resolution mechanisms for drug patents (“Patent Linkage”), effective July 4, 2021. Below is a summary highlighting key provisions and changes from the draft measures. Creation of an […]

Announcement: Implementation Regulations (Rules) of the Chinese Patent Law have been Approved

10 November 2023
On November 3rd, 2023, the Premier of the State Council, Li Qiang, chaired a regular meeting where the "Implementation Regulations of the Patent Law of the People's Republic of China (Revised Draft)" was reviewed and approved. This is great news, as we have been waiting quite some time for these Regulations (Rules) to be approved (see […]
Top crossarrow-right